Efg Asset Management (Americas) Corp. Ultragenyx Pharmaceutical Inc. Transaction History

Efg Asset Management (Americas) Corp.

  • $508 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 01, 2024
BUY
$31.73 - $49.19 $167,344 - $259,428
5,274 New
5,274 $252,000
Q4 2021

Jan 24, 2022
SELL
$73.71 - $87.86 $219,582 - $261,734
-2,979 Closed
0 $0
Q3 2021

Oct 22, 2021
BUY
$77.92 - $102.4 $232,123 - $305,049
2,979 New
2,979 $269,000

Others Institutions Holding RARE

# of Institutions
325
Shares Held
85.5M
Call Options Held
520K
Put Options Held
406K
View Full List

About Ultragenyx Pharmaceutical Inc.

RARE Quotes by TradingView
  • Ticker RARE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,036,896
  • Market Cap $3.14B
  • Description
  • Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...
More about RARE
Track This Portfolio

Track Efg Asset Management (Americas) Corp. Portfolio

Follow Efg Asset Management (Americas) Corp. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Efg Asset Management (Americas) Corp., based on Form 13F filings with the SEC.

News

Stay updated on Efg Asset Management (Americas) Corp. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email